What Has Been the Growth of the Medical Nitrous Oxide Market So Far?
The medical nitrous oxide market has seen considerable growth due to a variety of factors.
• The size of the medical nitrous oxide market has seen a rapid expansion over the past few years. The market will advance from a worth of $2.15 billion in 2024 to an estimated value of $2.37 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.3%.
Factors contributing to this growth during the historic period encompass the rise in surgical and dental procedures, enhanced understanding of pain control options, development of medical amenities, and the broadening of emergency medical services.
How Will the Medical Nitrous Oxide Market?
The medical nitrous oxide market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated to experience swift expansion in the upcoming years, the medical nitrous oxide market is projected to reach $3.47 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.2%.
Several factors such as the aging global population, increasing surgical procedures, preference for non-invasive pain management techniques, broadening scope of home healthcare services, and the adoption of nitrous oxide in dental procedures contribute to the growth forecasted for this period. This period is also expected to witness significant trends such as advancement in anesthesia techniques, technological innovation in gas delivery systems, their integration in dental practices, emergence of new medical applications and positive outcomes from clinical research.
Which Factors Are Boosting Growth In The Medical Nitrous Oxide Market?
The escalation in the requirement for pain management is predicted to stimulate the development of the medical nitrous oxide market in the future. This medical terminology concentrates on mitigating pain through an array of treatments such as medications, therapies, and procedures. The surge in the requirement for pain relief is linked to an increase in chronic pain incidence, older populations, and developments in treatment technologies and practices. Medical nitrous oxide aids in pain management by delivering fast and efficient analgesia during medical interventions. It triggers euphoria and sedation, which minimizes pain perception, assuring minor side effects and a swift recovery, making it the perfect choice for both minor surgical operations and dental procedures. For example, data from the Centers for Disease Control and Prevention, a government agency based in the U.S, reported that in 2023, 24.3% of U.S. adults endured chronic pain, with 8.5% indicating regular interference in their life or work activities. In 2021, this was lower at 20.9%, with 6.9% suffering from high-impact chronic pain. Consequently, the escalating demand for pain management is accelerating the growth of the medical nitrous oxide market.
What Key Areas Define The Segmentation Of The Global Medical Nitrous Oxide Market?
The medical nitrous oxide market covered in this report is segmented –
1) By Product: Gaseous State, Liquid State
2) By Purity Level: 98%-99% Medium Grade, 99.9% A-Z Grade, Below 98% Low Grade
3) By Application: Cryosurgery, Surgical Insufflation, Anesthesia And Pain Relief
4) By End User: Dental Clinics, Emergency Medical Services, Food Industry, Hospitals, Research Laboratories, Veterinary Clinics
Subsegments:
1) By Gaseous State: Compressed Gas Cylinders, Medical Gas Blends
2) By Liquid State: Cryogenic Liquid Nitrous Oxide, Liquid Nitrous Oxide For Medical Use
Pre-Book The Medical Nitrous Oxide Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Medical Nitrous Oxide Industry?
Key businesses in the medical nitrous oxide market are zeroing in on technological advancements such as superior drug delivery systems to boost the accuracy, security, and effectiveness of nitrous oxide use in medical scenarios. These state-of-the-art drug delivery systems are novel technologies developed to administer therapeutic gases or drugs to patients with precision, enhancing effectiveness, safety and patient adherence. For instance, in December 2023, Mallinckrodt plc, a pharmaceutical firm based in Ireland, secured clearance from the US Food and Drug Administration (FDA) for its INOmax EVOLVE DS delivery system, created to deliver INOmax (nitric oxide) gas via inhalation. The system guarantees a consistent NO concentration all through the breathing cycle with the help of an advanced injector module for exact, synchronized dosing. The system is validated for use with particular ventilators and respiratory apparatuses.
Who Are the Key Players In The Medical Nitrous Oxide Market?
Major companies operating in the medical nitrous oxide market are:
• Linde plc
• Air Liquide
• KVK Corporation
• Air Products and Chemicals Inc.
• Taiyo Nippon Sanso Corporation
• American Welding & Gas Inc.
• Messer SE & Co. KGaA
• Gulf Cryo
• Norco Inc.
• Ellenbarrie Industrial Gases Ltd.
• Earlbeck Gases & Technology
• CalOx Inc.
• Oxygen & Argon Works Ltd.
• Chengdu Taiyu Industrial Gases Co. Ltd.
• Southern Gas Limited
• Praxair Technology Inc.
• Satramdas Gases Pvt. Ltd.
• BOC Healthcare
• Carbide and Chemicals
• SOL SpA
• nexAir LLC
• Steelman Gases Pvt. Ltd.
• Jiangsu Huazhong Gas Co. Ltd.
• Vinayak Air Products Private Limited.
What Is The Most Dominant Region In The Medical Nitrous Oxide Market?
North America was the largest region in the medical nitrous oxide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical nitrous oxide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
